Skip to content
Aspivix logo
  • News
  • About us
  • Contact
Search
Close
  • For Healthcare Professionals
  • For Women
  • Resources
Stay Informed
Stay informed
Menu
  • For Healthcare Professionals
  • For Women
  • About us
  • Resources
  • News
  • Contact
Aspivix logo

Home > ASPIVIX’s Press Release featured in Investhirozon.eu

Untitled-design-10

ASPIVIX’s Press Release featured in Investhirozon.eu

December 14, 2020

Share this story:

Share on Facebook
Share on Linkedin
Share on Twitter

More from our blog

aspivix_MG_0208

A modern approach to women’s healthcare

Read More
aspivix_MG_0243

Clinical data show significantly lower IUD procedural pain and bleeding rates with Aspivix’s novel suction-based cervical device

Read More
News

Aspivix mentioned in Swissquote article about FemTech

Read More
News (1)

Reshaping gynecology with women’s experience in mind

Read More
News-4

Le grand débat – Santé des femmes, un marché porteur?

Read More
Lucy-Cohen-IUD-petition-980x551

Medical #metoo Drives Updates in IUD Guidelines

Read More
Untitled-design-3

La tech au service de la santé féminine lève 60 millions

Read More
News (2)

La santé des femmes intéresse enfin les investisseurs

Read More
Blog-header-image-2-980x551

Bridging the Gender Gap in Clinical Trials

Read More
pexels-george-milton-7034051-2-980x653

9 Books on Women’s Health & Gynecology

Read More

Company

Home
Product
Resources
Careers
Blog

Contact

Global Headquarters
Aspivix SA
Chemin du Closel 5
1020 Renens
Switzerland

Privacy Policy

Terms and Conditions

Healthcare marketing by Medico Digital

Disclaimer: Investigational Device Currently Under Development. Not Cleared Or Approved for sale in USA or any other market.